Figures & data
Figure 1 Protective effects of various forms of magnesium on blood glucose in DN rats after two months.
Notes: Data are mean ± SE of six animals. Difference between control and other groups is significant at P < 0.001(aaa). Difference between DN and 25Mg-PMC16 is significant at P < 0.05(b).
Abbreviations: DN, diabetic neuropathy; SE, standard error.
![Figure 1 Protective effects of various forms of magnesium on blood glucose in DN rats after two months.Notes: Data are mean ± SE of six animals. Difference between control and other groups is significant at P < 0.001(aaa). Difference between DN and 25Mg-PMC16 is significant at P < 0.05(b).Abbreviations: DN, diabetic neuropathy; SE, standard error.](/cms/asset/b659b313-6e2a-405b-b574-18182b16f961/dijn_a_12184633_f0001_c.jpg)
Figure 2 Protective effects of various forms of magnesium on weight of DN rats after two months.
Notes: Data are mean ± SE of six animals. Difference between control and other groups is significant at P < 0.001(aaa). Difference between DN and 25Mg-PMC16 is significant at P < 0.05(bb).
Abbreviations: DN, diabetic neuropathy; SE, standard error.
![Figure 2 Protective effects of various forms of magnesium on weight of DN rats after two months.Notes: Data are mean ± SE of six animals. Difference between control and other groups is significant at P < 0.001(aaa). Difference between DN and 25Mg-PMC16 is significant at P < 0.05(bb).Abbreviations: DN, diabetic neuropathy; SE, standard error.](/cms/asset/f328113f-18cf-42df-acbb-7968dc87bf3e/dijn_a_12184633_f0002_c.jpg)
Figure 3 Protective effects of various forms of magnesium on 2,3-DPG concentration in erythrocytes of DN rats after two months.
Notes: Data are mean ± SE of six animals. Difference between control and other groups is significant at P < 0.001(aaa). Difference between DN and 25Mg-PMC16 is significant at P < 0.001(bbb).
Abbreviations: DN, diabetic neuropathy; SE, standard error.
![Figure 3 Protective effects of various forms of magnesium on 2,3-DPG concentration in erythrocytes of DN rats after two months.Notes: Data are mean ± SE of six animals. Difference between control and other groups is significant at P < 0.001(aaa). Difference between DN and 25Mg-PMC16 is significant at P < 0.001(bbb).Abbreviations: DN, diabetic neuropathy; SE, standard error.](/cms/asset/e7b33aa0-fe84-4da1-8ec6-f9048ad79bc6/dijn_a_12184633_f0003_c.jpg)
Table 1 Protective effects of various forms of magnesium on oxidative stress biomarkers
Figure 4 Protective effects of various forms of magnesium on ADP/ATP level in DN rats after two months.
Notes: Data are mean ± SE of six animals. Difference between control and other groups is significant at P < 0.001(aaa). Difference between DN and 25Mg-PMC16 is significant at P < 0.001(bbb).
Abbreviations: ADP/ATP, adenosine diphosphate/adenosine triphospahte; DN, diabetic neuropathy; SE, standard error.
![Figure 4 Protective effects of various forms of magnesium on ADP/ATP level in DN rats after two months.Notes: Data are mean ± SE of six animals. Difference between control and other groups is significant at P < 0.001(aaa). Difference between DN and 25Mg-PMC16 is significant at P < 0.001(bbb).Abbreviations: ADP/ATP, adenosine diphosphate/adenosine triphospahte; DN, diabetic neuropathy; SE, standard error.](/cms/asset/d6299d9b-31b8-439b-b385-747186cb8a85/dijn_a_12184633_f0004_c.jpg)